Wells Fargo Lowers Alphabet Price Target to $361
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 02 2026
0mins
Should l Buy GOOGL?
Wells Fargo lowered the firm's price target on Alphabet to $361 from $397 and keeps an Overweight rating on the shares. The firm sees Q1 as positive inflection in free cash flow revisions, with expected upward revenue and OI estimate revisions combined with steady CapEx after period of sustained pressure on free cash flow estimates. Further, Wells sees estimate upside driven mostly by non-cyclical factors, namely GCP.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GOOGL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GOOGL
Wall Street analysts forecast GOOGL stock price to rise
33 Analyst Rating
26 Buy
7 Hold
0 Sell
Strong Buy
Current: 305.460
Low
305.00
Averages
374.25
High
400.00
Current: 305.460
Low
305.00
Averages
374.25
High
400.00
About GOOGL
Alphabet Inc. is a holding company. The Company's segments include Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment includes infrastructure and platform services, collaboration tools, and other services for enterprise customers. Its Other Bets segment is engaged in the sale of healthcare-related services and Internet services. Its Google Cloud provides enterprise-ready cloud services, including Google Cloud Platform and Google Workspace. Google Cloud Platform provides access to solutions such as artificial intelligence (AI) offerings, including its AI infrastructure, Vertex AI platform, and Gemini for Google Cloud; cybersecurity, and data and analytics. Google Workspace includes cloud-based communication and collaboration tools for enterprises, such as Calendar, Gmail, Docs, Drive, and Meet.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Alphabet Emerges as a High-Quality Cash Flow Franchise
- Market Environment Improvement: With the establishment of a ceasefire framework in Iran and a sharp decline in oil prices, Alphabet showcases its strong cash flow characteristics at a time when the macro backdrop is shifting towards quality growth, potentially attracting more investor interest in its long-term growth prospects.
- Technical Support Recovery: Alphabet's stock price has reclaimed the $310 resistance level, indicating that market risk appetite for large-cap tech stocks is improving after geopolitical volatility, which could pave the way for further upside.
- AI Full-Stack Advantage: As the only company with comprehensive AI capabilities, Alphabet's strong presence across chips, cloud computing, and research positions it as a leader in the AI market, enhancing investor confidence in its future profitability.
- Self-Funding Cash Flow: Alphabet's ability to aggressively invest in chips and cloud capabilities while generating substantial free cash flow provides it with a significant edge in the AI competition, further solidifying its market position.
See More
Meta Unveils New AI Model Muse Spark Amid Strategic Shift
- AI Model Launch: Meta has unveiled its first new AI model, Muse Spark, after over a year of silence, marking a strategic shift from open-source to proprietary models under the leadership of Scale AI co-founder Alexandr Wang, aiming to identify new revenue streams.
- Massive Investment Returns: Over the past 10 months, Meta has invested more than $14 billion to recruit Wang and his team; although new revenue streams have yet to materialize, analysts believe this move is crucial for demonstrating the company's commitment to AI to investors.
- Core Advertising Business: With advertising accounting for 98% of Meta's $200 billion total revenue, analysts emphasize that enhancements in AI technology will make ads more engaging and targeted, driving advertisers to reinvest, thereby solidifying Meta's market position.
- Competitive Market Pressure: Despite significant investments in AI, Meta faces intense competition from rivals like OpenAI and Anthropic; analysts warn that the company must ensure its new model is technically competitive to maintain relevance in the rapidly evolving AI landscape.
See More
Market Dynamics and AI Investment Updates
- Market Volatility: The Dow Jones Industrial Average surged over 1,300 points yesterday, marking its best performance of the year, despite Iran's accusations against the U.S. for breaching the ceasefire agreement, indicating market resilience amid geopolitical tensions.
- AI Industry Challenges: Anthropic's attempt to temporarily block its blacklisting by the Department of Defense was denied by a federal appeals court, highlighting increasing government scrutiny over AI technologies, which may impact the market outlook for related companies.
- Interest Rate Expectations Shift: Minutes from the Federal Reserve's meeting revealed that officials still expect potential interest rate cuts this year despite uncertainties, with market-implied odds of a cut rising from 14% to 43%, reflecting a reassessment of economic prospects by investors.
- Meta AI Model Launch: Meta debuted its first AI model Muse Spark, developed with Scale AI, marking a strategic shift in its approach to the AI market; the success of this model will directly influence its future revenue streams amid fierce competition.
See More
Moderna and Target Stocks Show Recovery
- Moderna Stock Surge: Since the beginning of the year, Moderna's stock has surged nearly 70%, driven by the launch of new vaccine products and a focus on seasonal vaccines, with expectations of up to 10% revenue growth this year, indicating a recovery that is attracting investor interest.
- Vaccine Revenue Support: After generating over $18 billion in vaccine revenue in 2022, Moderna is reshaping its revenue structure by introducing new COVID-19 and RSV vaccines, with seasonal vaccines expected to drive the development of other programs.
- Target's Strategic Transformation: Target's stock has risen over 20% since the start of the year, thanks to a $200 million investment plan by new CEO Michael Fiddelke aimed at improving product displays, refreshing the product assortment, and enhancing employee training to boost customer experience and sales growth.
- Competitive Advantage Enhancement: Despite pressure from competitors like Walmart, Target's lower forward P/E ratio of 14x compared to peers indicates greater growth potential, suggesting that its recovery story in the retail market is ongoing and attracting investor attention.
See More
Investors Shift Focus to Healthcare and Retail Stocks
- Market Shift: In an uncertain market, investors are turning to healthcare and retail stocks, perceived as 'safer' investments due to their potential for revenue stability, reflecting concerns over slowing economic growth.
- Moderna's Recovery: Moderna generated over $18 billion from its COVID-19 vaccine during the pandemic's early days, but its stock plummeted 90% as demand waned; however, investors are now returning, anticipating up to 10% revenue growth in 2023 as it focuses on seasonal vaccines, oncology, and rare diseases.
- Target's Transformation: Target benefited from digital initiatives during the pandemic but faced challenges afterward; new CEO Michael Fiddelke has launched a multi-year $2 billion investment plan to enhance product displays and employee training, resulting in a stock price increase of over 20% since the start of the year.
- Investment Opportunities: With increasing market interest in healthcare and retail stocks, the recovery narratives of Moderna and Target are attracting investors, particularly as Target's price-to-earnings ratio stands at just 14 times, significantly lower than its competitors, indicating substantial growth potential ahead.
See More
Meta Commits Additional $21 Billion to AI Infrastructure
- Investment Expansion: Meta has committed an additional $21 billion to CoreWeave, following a prior agreement of $14.2 billion, highlighting its ongoing focus on AI infrastructure and enhancing its competitive edge in the AI sector.
- Infrastructure Demand: CoreWeave's data centers, equipped with hundreds of thousands of Nvidia GPUs, cater to the needs of hyperscalers like Meta for AI models, indicating Meta's reliance on external infrastructure to meet the immense market demand during rapid expansion.
- Capital Expenditure Plans: Meta plans to spend between $115 billion and $135 billion on capital expenditures in 2023, significantly exceeding Wall Street estimates, reflecting its confidence in AI technology and the potential of its core advertising business.
- Customer Diversification Strategy: CoreWeave's CEO noted that the new agreement will diversify its customer base, reducing reliance on Microsoft, and is expected to strengthen the partnership with Meta, thereby mitigating business risks and enhancing market competitiveness.
See More
Alphabet Emerges as a High-Quality Cash Flow Franchise
- Market Environment Improvement: With the establishment of a ceasefire framework in Iran and a sharp decline in oil prices, Alphabet showcases its strong cash flow characteristics at a time when the macro backdrop is shifting towards quality growth, potentially attracting more investor interest in its long-term growth prospects.
- Technical Support Recovery: Alphabet's stock price has reclaimed the $310 resistance level, indicating that market risk appetite for large-cap tech stocks is improving after geopolitical volatility, which could pave the way for further upside.
- AI Full-Stack Advantage: As the only company with comprehensive AI capabilities, Alphabet's strong presence across chips, cloud computing, and research positions it as a leader in the AI market, enhancing investor confidence in its future profitability.
- Self-Funding Cash Flow: Alphabet's ability to aggressively invest in chips and cloud capabilities while generating substantial free cash flow provides it with a significant edge in the AI competition, further solidifying its market position.
See More
Meta Unveils New AI Model Muse Spark Amid Strategic Shift
- AI Model Launch: Meta has unveiled its first new AI model, Muse Spark, after over a year of silence, marking a strategic shift from open-source to proprietary models under the leadership of Scale AI co-founder Alexandr Wang, aiming to identify new revenue streams.
- Massive Investment Returns: Over the past 10 months, Meta has invested more than $14 billion to recruit Wang and his team; although new revenue streams have yet to materialize, analysts believe this move is crucial for demonstrating the company's commitment to AI to investors.
- Core Advertising Business: With advertising accounting for 98% of Meta's $200 billion total revenue, analysts emphasize that enhancements in AI technology will make ads more engaging and targeted, driving advertisers to reinvest, thereby solidifying Meta's market position.
- Competitive Market Pressure: Despite significant investments in AI, Meta faces intense competition from rivals like OpenAI and Anthropic; analysts warn that the company must ensure its new model is technically competitive to maintain relevance in the rapidly evolving AI landscape.
See More
Market Dynamics and AI Investment Updates
- Market Volatility: The Dow Jones Industrial Average surged over 1,300 points yesterday, marking its best performance of the year, despite Iran's accusations against the U.S. for breaching the ceasefire agreement, indicating market resilience amid geopolitical tensions.
- AI Industry Challenges: Anthropic's attempt to temporarily block its blacklisting by the Department of Defense was denied by a federal appeals court, highlighting increasing government scrutiny over AI technologies, which may impact the market outlook for related companies.
- Interest Rate Expectations Shift: Minutes from the Federal Reserve's meeting revealed that officials still expect potential interest rate cuts this year despite uncertainties, with market-implied odds of a cut rising from 14% to 43%, reflecting a reassessment of economic prospects by investors.
- Meta AI Model Launch: Meta debuted its first AI model Muse Spark, developed with Scale AI, marking a strategic shift in its approach to the AI market; the success of this model will directly influence its future revenue streams amid fierce competition.
See More
Moderna and Target Stocks Show Recovery
- Moderna Stock Surge: Since the beginning of the year, Moderna's stock has surged nearly 70%, driven by the launch of new vaccine products and a focus on seasonal vaccines, with expectations of up to 10% revenue growth this year, indicating a recovery that is attracting investor interest.
- Vaccine Revenue Support: After generating over $18 billion in vaccine revenue in 2022, Moderna is reshaping its revenue structure by introducing new COVID-19 and RSV vaccines, with seasonal vaccines expected to drive the development of other programs.
- Target's Strategic Transformation: Target's stock has risen over 20% since the start of the year, thanks to a $200 million investment plan by new CEO Michael Fiddelke aimed at improving product displays, refreshing the product assortment, and enhancing employee training to boost customer experience and sales growth.
- Competitive Advantage Enhancement: Despite pressure from competitors like Walmart, Target's lower forward P/E ratio of 14x compared to peers indicates greater growth potential, suggesting that its recovery story in the retail market is ongoing and attracting investor attention.
See More
Investors Shift Focus to Healthcare and Retail Stocks
- Market Shift: In an uncertain market, investors are turning to healthcare and retail stocks, perceived as 'safer' investments due to their potential for revenue stability, reflecting concerns over slowing economic growth.
- Moderna's Recovery: Moderna generated over $18 billion from its COVID-19 vaccine during the pandemic's early days, but its stock plummeted 90% as demand waned; however, investors are now returning, anticipating up to 10% revenue growth in 2023 as it focuses on seasonal vaccines, oncology, and rare diseases.
- Target's Transformation: Target benefited from digital initiatives during the pandemic but faced challenges afterward; new CEO Michael Fiddelke has launched a multi-year $2 billion investment plan to enhance product displays and employee training, resulting in a stock price increase of over 20% since the start of the year.
- Investment Opportunities: With increasing market interest in healthcare and retail stocks, the recovery narratives of Moderna and Target are attracting investors, particularly as Target's price-to-earnings ratio stands at just 14 times, significantly lower than its competitors, indicating substantial growth potential ahead.
See More
Meta Commits Additional $21 Billion to AI Infrastructure
- Investment Expansion: Meta has committed an additional $21 billion to CoreWeave, following a prior agreement of $14.2 billion, highlighting its ongoing focus on AI infrastructure and enhancing its competitive edge in the AI sector.
- Infrastructure Demand: CoreWeave's data centers, equipped with hundreds of thousands of Nvidia GPUs, cater to the needs of hyperscalers like Meta for AI models, indicating Meta's reliance on external infrastructure to meet the immense market demand during rapid expansion.
- Capital Expenditure Plans: Meta plans to spend between $115 billion and $135 billion on capital expenditures in 2023, significantly exceeding Wall Street estimates, reflecting its confidence in AI technology and the potential of its core advertising business.
- Customer Diversification Strategy: CoreWeave's CEO noted that the new agreement will diversify its customer base, reducing reliance on Microsoft, and is expected to strengthen the partnership with Meta, thereby mitigating business risks and enhancing market competitiveness.
See More
